CAS 102686-43-1 Atrial Natriuretic Peptide (3-28)(human)

Send Inquiry
CAS 102686-43-1 Atrial Natriuretic Peptide (3-28)(human)
Details
Human ANP(3-28);
Category: Natriuretic peptide / ANP metabolite.
Peptide Purity (HPLC) ≥95%
CAS No. 102686-43-1
Structure 26-mer natriuretic peptide (human ANP 3-28, disulfide ring)
Solubility Water, dilute acetic acid/saline
Storage Powder, −20°C, dry, light-protected
Category
Hormone Peptide
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 102686-43-1 atrial natriuretic peptide (3-28)(human) in China, also supports custom service. Welcome to wholesale bulk high quality cas 102686-43-1 atrial natriuretic peptide (3-28)(human) from our factory. Contact us for more details.

 

Description A DPP4-processed metabolite of mature ANP(1-28) retaining partial natriuretic activity; used for ANP metabolism studies.

 

Product Basic Information Table

 

Product Name (EN) Synonyms / Aliases Functional Tags Structure (3-letter sequence) Molecular Formula Monoisotopic MW (Da) Average MW (Da) Salt Form Length (aa)
Atrial Natriuretic Peptide (3-28), human hANP (3-28); Atrial Natriuretic Factor (3-28); ANF (3-28); CAS 102686-43-1; 26 aa; intramolecular Cys5-Cys21 disulfide loop; contains Met10 Atrial natriuretic peptide, ANP, NPR-A (GC-A) agonist, Natriuretic/diuretic, Vasodilator, Antihypertensive, cGMP signaling, Disulfide cyclic peptide, Cardiovascular hormone Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Cys5-Cys21 disulfide) C118H187N43O36S3 2878.33 2880.23 Free peptide (TFA/acetate salt available) 26

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-ANP328-01 White to off-white powder Store at -20°C, protected from light, desiccated and sealed; aliquot to avoid repeated freeze-thaw. Contains an intramolecular disulfide bond (Cys5-Cys21) - DO NOT use DTT/TCEP/β-mercaptoethanol reducing agents. Contains Met10, which is prone to oxidation to methionine sulfoxide; minimize exposure to oxidants and prolonged air contact. Stable for several days at 2–8°C protected from light; after reconstitution, aliquot and store at -20°C. Readily soluble in water or weakly acidic buffer (e.g. 10–20% acetic acid, pH 4–5 ammonium acetate). Use reconstituted solution short-term at 2–8°C (preferably within 24–48 h); for longer storage, aliquot and freeze at -20°C. Met10 is readily oxidized by air/oxidants to Met(O); prepare fresh before use and avoid repeated freeze-thaw. Stable for 2–3 years as a dry powder when sealed and desiccated at -20°C. TFA salt is hygroscopic - keep in a desiccator after opening.

 

Functional Description

 

Product Code Short Summary Detailed Biological Description Research Areas Target / Receptor
PEP-ANP328-01 A 26-aa human atrial natriuretic peptide fragment (3-28); Cys5-Cys21 form the conserved 17-membered disulfide loop that activates NPR-A (GC-A) to raise cGMP, producing natriuresis, diuresis, vasodilation and suppression of renin–aldosterone release. Human atrial natriuretic peptide (ANP) is a 28-aa cardiac hormone (ANP 1-28: SLRRSSCFGGRMDRIGAQSGLGCNSFRY) synthesized and secreted by atrial myocytes in response to wall stretch. ANP (3-28) is the 26-aa active fragment generated by removal of the N-terminal Ser-Leu dipeptide, retaining the essential intramolecular Cys5-Cys21 disulfide loop required for receptor binding and bioactivity. It acts primarily by binding and activating the guanylyl cyclase-A receptor (NPR-A/GC-A), which catalyzes cGMP production and activates downstream PKG signaling, resulting in: (1) dilation of the afferent renal arteriole and increased GFR, promoting sodium and water excretion (natriuresis/diuresis); (2) relaxation of vascular smooth muscle, reducing peripheral resistance and blood pressure; (3) suppression of the renin–angiotensin–aldosterone system (RAAS), lowering aldosterone and vasopressin; (4) inhibition of cardiac fibroblast proliferation and anti-hypertrophic/anti-remodeling effects. Compared with full-length ANP (1-28), ANP (3-28) shows altered affinity for the NPR-C clearance receptor and different circulatory stability, making it useful for NPR-A pharmacology, cardiovascular diuretic/antihypertensive studies, heart failure models and natriuretic peptide system research. Met10 is oxidation-sensitive; prepare solutions fresh. Cardiovascular pharmacology, Blood pressure and volume regulation, Natriuretic peptide system (NPR-A/GC-A), Heart failure and cardiac hypertrophy, Diuresis and salt-water balance, RAAS, cGMP signaling NPR-A (Natriuretic Peptide Receptor A / Guanylyl Cyclase A, GC-A) agonist; also a ligand for the NPR-C clearance receptor

 

 

 

 

Hot Tags: cas 102686-43-1 atrial natriuretic peptide (3-28)(human), China cas 102686-43-1 atrial natriuretic peptide (3-28)(human) manufacturers, suppliers, factory, 161748-29-4, 76461-17-1, ACTH 1 14 , CAS 23815 91 0, hormone peptide, Somatostatin-25

Send Inquiry